LAMAinDiab
LAMAinDiab – lisdexamphetamine vs metylphenidate for pediatric patients with attention-deficit hyperactivity disorder and type 1 diabetes – randomized cross-over clinical trial
LAMAinDiab – lisdexamphetamine vs metylphenidate for pediatric patients with attention-deficit hyperactivity disorder and type 1 diabetes – randomized cross-over clinical trial